Bacitracin og/eller daptomycin kombineret med cannabidiol til behandling af bakterieinfektioner

Publikation: Patent

Abstract

The present invention relates to compositions comprising Cannabidiol (CBD) or pharmaceutically acceptable salts thereof, and bacitracin or pharmaceutically acceptable salts thereof and/or daptomycin or pharmaceutically acceptable salts thereof. The compositions show a synergistic effect in the inhibition of growth of Gram-positive bacteria. Thus, the compositions according to the invention may e.g. find use as medicaments in the treatment of Gram-positive bacterial infections.
OriginalsprogDansk
IPCA61K31/352,A61K38/12,A61K45/06,A61L27/54,A61L29/16,A61P31/04
PatentnummerDK3641753 (T3)
Land/OmrådeDanmark
Prioritetsdato19/06/2017
PrioritetsnummerWO2018EP66234
StatusUdgivet - 12. dec. 2022

Citationsformater